Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NasdaqCM - Delayed Quote USD

PharmaCyte Biotech, Inc. (PMCB)

Compare
1.7800
+0.0500
+(2.89%)
At close: March 7 at 4:00:01 PM EST
Advanced Chart
Loading Chart for PMCB
  • Previous Close 1.7300
  • Open 1.6728
  • Bid 1.2400 x 200
  • Ask 2.3000 x 200
  • Day's Range 1.6728 - 1.7986
  • 52 Week Range 1.3900 - 2.5800
  • Volume 6,880
  • Avg. Volume 18,494
  • Market Cap (intraday) 12.403M
  • Beta (5Y Monthly) -0.25
  • PE Ratio (TTM) 2.02
  • EPS (TTM) 0.8800
  • Earnings Date Mar 17, 2025 - Mar 21, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

PharmaCyte Biotech, Inc., a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. The company develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; and license agreements with SG Austria Pte. Ltd. and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.

pharmacyte.com

2

Full Time Employees

April 30

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about PharmaCyte Biotech, Inc.

Recent News: PMCB

View More
View More

Performance Overview: PMCB

Trailing total returns as of 3/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 .

YTD Return

PMCB
13.38%
S&P 500
1.89%

1-Year Return

PMCB
13.17%
S&P 500
11.88%

3-Year Return

PMCB
16.82%
S&P 500
37.35%

5-Year Return

PMCB
97.70%
S&P 500
94.13%

Compare To: PMCB

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

PMCB
PharmaCyte Biotech, Inc.
1.7800
+2.89%
Mkt Cap 12.403M
Industry Biotechnology
LIXT
Lixte Biotechnology Holdings, Inc.
1.2000
0.00%
Mkt Cap 3.221M
Industry Biotechnology
PRQR
ProQR Therapeutics N.V.
1.9100
-1.55%
Mkt Cap 202.282M
Industry Biotechnology
TCRT
Alaunos Therapeutics, Inc.
1.6200
+7.28%
Mkt Cap 2.594M
Industry Biotechnology
GKO.BE
GlycoMimetics Inc
0.2445
+2.52%
Mkt Cap EUR -
Industry Biotechnology
R3X1.BE
Ocuphire Pharma Inc
0.9090
-0.44%
Mkt Cap EUR -
Industry Biotechnology
BZYR
Burzynski Research Institute, Inc.
0.0580
0.00%
Mkt Cap 7.624M
Industry Biotechnology
GLMD
Galmed Pharmaceuticals Ltd.
1.8879
+0.96%
Mkt Cap 3.128M
Industry Biotechnology
FOLD
Amicus Therapeutics, Inc.
8.86
-1.77%
Mkt Cap 2.722B
Industry Biotechnology
NMTRQ
9 Meters Biopharma, Inc.
0.0001
0.00%
Mkt Cap 1,446
Industry Biotechnology
KPRX
Kiora Pharmaceuticals, Inc.
3.2500
-1.52%
Mkt Cap 9.753M
Industry Biotechnology

Statistics: PMCB

View More

Valuation Measures

Annual
As of 3/7/2025

  • Market Cap

    11.99M

  • Enterprise Value

    -8.85M

  • Trailing P/E

    1.95

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.28

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -5.05%

  • Return on Equity (ttm)

    43.18%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    9.42M

  • Diluted EPS (ttm)

    0.8800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    20.84M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    522.67k

View More

Research Analysis: PMCB

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings --

Q3'21

Q4'21

Q1'22

Q2'22

0
 
View More

Company Insights: PMCB

People Also Watch

VRPX Virpax Pharmaceuticals, Inc.
0.1935
+3.48%
 
AMMJ American Cannabis Company, Inc.
0.0003
-70.00%
 
NAOV NanoVibronix, Inc.
0.3579
+2.08%
 
AGTK Agritek Holdings, Inc.
0.0001
0.00%
 
PLPL Plandaí Biotechnology, Inc.
0.0001
0.00%
 
GRNH GreenGro Technologies, Inc.
0.0000
0.00%
 
XBIO Xenetic Biosciences, Inc.
3.7650
-0.92%
 
SNOA Sonoma Pharmaceuticals, Inc.
1.9900
-8.29%
 
SONN Sonnet BioTherapeutics Holdings, Inc.
1.4900
+3.47%
 
NURO NeuroMetrix, Inc.
4.3800
-0.45%
 
NRXP NRx Pharmaceuticals, Inc.
2.1700
+0.46%
 
CBDS Dogecoin Cash, Inc.
0.0408
+2.00%
 
GOVX GeoVax Labs, Inc.
1.7100
-6.56%
 
RNXT RenovoRx, Inc.
0.9570
-1.53%
 
NDEV Novus Acquisition & Development Corp.
0.0436
+6.08%
 
ATTBF Abattis Bioceuticals Corp.
0.0001
0.00%